Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Trevor Stump, Jessica Cather & Pamela S. Moore. (2020) The effects of cytochrome P450 2D6 inhibitors on a high-dose tramadol taper for medically supervised opioid withdrawal: a retrospective chart review. Journal of Addictive Diseases 39:1, pages 81-87.
Read now
Read now
Jacob A. Radcliff, Suman C. Vellanki, Pamela S. Moore, Barbara J. Weisensell & Jessica K. Cather. (2018) A retrospective chart review of outcomes resulting from a three-day tramadol taper for acute opioid withdrawal. Journal of Addictive Diseases 37:3-4, pages 252-258.
Read now
Read now
Mehran Zarghami, Babak Masoum & Mohammad-Reza Shiran. (2012) Tramadol versus Methadone for Treatment of Opiate Withdrawal: A Double-Blind, Randomized, Clinical Trial. Journal of Addictive Diseases 31:2, pages 112-117.
Read now
Read now
Ryan M. Caldiero, Theodore V. Parran$suffix/text()$suffix/text(), Christopher L. Adelman & Betty Piche. (2006) Inpatient Initiation of Buprenorphine Maintenance vs. Detoxification: Can Retention of Opioid-Dependent Patients in Outpatient Counseling Be Improved?. American Journal on Addictions 15:1, pages 1-7.
Read now
Read now
SidneyH. Schnoll. (2004) The Emperor's New Clothes. Journal of Addictive Diseases 22:4, pages 1-4.
Read now
Read now
Articles from other publishers (12)
Zhenxiang Gao, Pingjian Ding & Rong Xu. (2023) IUPHAR review - Data-driven Computational Drug Repurposing Approaches for Opioid Use Disorder. Pharmacological Research, pages 106960.
Crossref
Crossref
Kaushal Shah, Billy Stout & Hunter Caskey. (2020) Tramadol for the Management of Opioid Withdrawal: A Systematic Review of Randomized Clinical Trials. Cureus.
Crossref
Crossref
Esther Blessing, Sanya Virani & John Rotrosen. 2020. Substance Use Disorders. Substance Use Disorders
167
202
.
Ebru Findikli & Hatice Altun. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
417
422
.
Morteza Gholami, Ehsan Saboory & Shiva Roshan-Milani. (2014) Proconvulsant effects of tramadol and morphine on pentylenetetrazol-induced seizures in adult rats using different routes of administration. Epilepsy & Behavior 36, pages 90-96.
Crossref
Crossref
Caroline Strasinger, Kalpana S. Paudel, Ji Wu, Dana Hammell, Raghotham R. Pinninti, Bruce J. Hinds & Audra Stinchcomb. (2014) Programmable Transdermal Clonidine Delivery Through Voltage-Gated Carbon Nanotube Membranes. Journal of Pharmaceutical Sciences 103:6, pages 1829-1838.
Crossref
Crossref
Michelle R. Lofwall, Shanna Babalonis, Paul A. Nuzzo, Anthony Siegel, Charles Campbell & Sharon L. Walsh. (2013) Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: A two-phase randomized controlled trial. Drug and Alcohol Dependence 133:1, pages 188-197.
Crossref
Crossref
Ted Parran. 2013. Medical Management of the Surgical Patient. Medical Management of the Surgical Patient
481
490
.
Miriam Z. Mintzer, Ryan K. Lanier, Michelle R. Lofwall, George E. Bigelow & Eric C. Strain. (2010) Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers. Drug and Alcohol Dependence 111:3, pages 265-268.
Crossref
Crossref
Ryan K. Lanier, Michelle R. Lofwall, Miriam Z. Mintzer, George E. Bigelow & Eric C. Strain. (2010) Physical dependence potential of daily tramadol dosing in humans. Psychopharmacology 211:4, pages 457-466.
Crossref
Crossref
Michelle R. Lofwall, Sharon L. Walsh, George E. Bigelow & Eric C. Strain. (2007) Modest opioid withdrawal suppression efficacy of oral tramadol in humans. Psychopharmacology 194:3, pages 381-393.
Crossref
Crossref
C. Patrick Carroll, Sharon L. Walsh, George E. Bigelow, Eric C. Strain & Kenzie L. Preston. (2006) Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans.. Experimental and Clinical Psychopharmacology 14:2, pages 109-120.
Crossref
Crossref